Laura Kruper

2.5k total citations
66 papers, 1.7k citations indexed

About

Laura Kruper is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, Laura Kruper has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 29 papers in Cancer Research and 11 papers in Epidemiology. Recurrent topics in Laura Kruper's work include Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Treatment and Pharmacology (11 papers). Laura Kruper is often cited by papers focused on Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Treatment and Pharmacology (11 papers). Laura Kruper collaborates with scholars based in United States, Mexico and Saudi Arabia. Laura Kruper's co-authors include Joanne Mortimer, Kyuwan Lee, Christina M. Dieli‐Conwright, Katherine Henderson, Leslie Bernstein, George Somlo, John H. Yim, Colt A. Egelston, Heehyoung Lee and Peter P. Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Laura Kruper

59 papers receiving 1.6k citations

Peers

Countries citing papers authored by Laura Kruper

Since Specialization

Citations

This map shows the geographic impact of Laura Kruper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Kruper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Kruper more than expected).

Fields of papers citing papers by Laura Kruper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Kruper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Kruper. The network helps show where Laura Kruper may publish in the future.

Co-authorship network of co-authors of Laura Kruper

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Kruper. A scholar is included among the top collaborators of Laura Kruper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Kruper. Laura Kruper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health Initiative 2024 ·Breast Cancer Research and Treatment ·Rebecca A. Nelson, Rowan T. Chlebowski, Kathy Pan, Thomas E. Rohan, Joanne Mortimer, Jean Wactawski‐Wende, Dorothy S. Lane, Laura Kruper	3
2	Retrieval of the Clipped Axillary Lymph Node and Its Impact on Treatment Decisions 2024 ·Cancers ·(unknown), (unknown), Junmin Whiting, Weihong Sun, Brian J. Czerniecki, Susan Hoover, Nazanin Khakpour, John V. Kiluk, Christine Laronga, Melissa Anne Mallory, Marie Catherine Lee, Laura Kruper	0
3	Bilateral Oophorectomy and Colorectal Cancer Incidence and Mortality in the Women's Health Initiative 2023 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Rebecca A. Nelson, Laura Kruper, Joanne Mortimer, Juhua Luo, Su Yon Jung, Robert B. Wallace, Rowan T. Chlebowski	1
4	Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer 2022 ·JCI Insight ·Colt A. Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L. Simons, (unknown), Yinghui Huang, Michael S. Nelson, (unknown), Daniel Schmolze, John H. Yim, Laura Kruper, Laleh G. Melstrom, Kim Margolin, Joanne Mortimer, Yuan Yuan, James Waisman, Peter P. Lee	25
5	Phase 2 prospective open label study of neoadjuvant nab‐paclitaxel, trastuzumab, and pertuzumab in patients with HER2‐positive primary breast cancer 2022 ·Cancer ·Sayeh Lavasani, George Somlo, Susan E. Yost, Paul Frankel, Christopher Ruel, (unknown), (unknown), (unknown), (unknown), Laura Kruper, Lusine Tumyan, Daniel Schmolze, Christina Yeon, Yuan Yuan, James Waisman, Joanne Mortimer	5
6	Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care 2020 ·Journal of Clinical Medicine ·Joanne Mortimer, Laura Kruper, Mary Cianfrocca, Sayeh Lavasani, (unknown), (unknown), Mina S. Sedrak, (unknown), Daphne Stewart, James Waisman, Christina Yeon, Tina Wang, Yuan Yuan	3
7	Insurance Status Predicts Survival in Women with Breast Cancer: Results of Breast and Cervical Cancer Treatment Program in California 2020 ·Annals of Surgical Oncology ·Rebecca A. Nelson, (unknown), Veronica Jones, Joanne Mortimer, (unknown), Leslie Taylor, Xuhui Lee, John H. Yim, Laura Kruper	9
8	Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812) 2019 ·Cancer Prevention Research ·Katherine D. Crew, Garnet L. Anderson, Dawn L. Hershman, Mary Beth Terry, Parisa Tehranifar, Danika L. Lew, Monica Yee, Eric Brown, (unknown), (unknown), Therese B. Bevers, John E. Doster, Corrine Zarwan, Laura Kruper, Lori M. Minasian, Leslie G. Ford, Banu Arun, Marian L. Neuhouser, Gary E. Goodman, Powel H. Brown	16
9	Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression 2018 ·Nature Communications ·Colt A. Egelston, Christian Avalos, Travis Y. Tu, Diana L. Simons, (unknown), Jae Yoon Jung, Laleh G. Melstrom, Kim Margolin, John H. Yim, Laura Kruper, Joanne Mortimer, Peter P. Lee	97
10	Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2− and ER+HER2+) breast cancers 2016 ·The Journal of Steroid Biochemistry and Molecular Biology ·Noriko Kanaya, George Somlo, Jun Wu, Paul Frankel, Masaya Kai, Xueli Liu, (unknown), Duc Nguyen, (unknown), (unknown), (unknown), Laura Kruper, (unknown), Behnam Badie, John H. Yim, Yuan Yuan, Arti Hurria, (unknown), Joanne Mortimer, Shiuan Chen	21
11	Time to Treatment: Measuring Quality Breast Cancer Care 2016 ·Annals of Surgical Oncology ·(unknown), Rebecca A. Nelson, (unknown), Veronica Jones, Lily Lai, Joanne Mortimer, Leslie Taylor, (unknown), John H. Yim, Laura Kruper	76
12	Predictors of Antiestrogen Recommendation in Women With Estrogen Receptor–Positive Ductal Carcinoma In Situ 2016 ·Journal of the National Comprehensive Cancer Network ·Rondi M. Kauffmann, Leanne Goldstein, (unknown), George Somlo, Yuan Yuan, Philip H. G. Ituarte, Laura Kruper, Leslie Taylor, (unknown)	4
13	Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer 2015 ·JNCI Journal of the National Cancer Institute ·Sunita K. Patel, Andrew L. Wong, F. Lennie Wong, Elizabeth C. Breen, Arti Hurria, Mackenzie Smith, (unknown), I. Benjamin Paz, Laura Kruper, George Somlo, Joanne Mortimer, Melanie R. Palomares, Michael R. Irwin, Smita Bhatia	86
14	Patterns and Trends in Immediate Postmastectomy Reconstruction in California 2015 ·Plastic & Reconstructive Surgery ·Shaila J. Merchant, Leanne Goldstein, Laura Kruper	18
15	Tumor Response Ratio Predicts Overall Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy 2014 ·Annals of Surgical Oncology ·Marian H. Miller, Rebecca A. Ottesen, Joyce C. Niland, Laura Kruper, Steven L. Chen, (unknown)	14
16	Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy 2014 ·Breast Cancer Research and Treatment ·Joanne Mortimer, Jae Yeon Jung, Yuan Yuan, Laura Kruper, Daphne Stewart, (unknown), (unknown), (unknown), Massimo D’Apuzzo, Bernard Tegtmeier, Sanjeet Dadwal	13
17	Rural and urban disparities in the evolution of sentinel lymph node utilization in breast cancer 2013 ·The American Journal of Surgery ·Amanda K. Arrington, Laura Kruper, (unknown), John H. Yim, Joseph Kim, Steven L. Chen	17
18	Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of Care and Factors Associated with the Use of Breast Reconstruction for DCIS Compared with Invasive Cancer 2011 ·Annals of Surgical Oncology ·Laura Kruper, Xinxin Xu, Katherine Henderson, Leslie Bernstein	51
19	Sentinel lymph node biopsy indications and controversies in breast cancer 2011 ·Maturitas ·(unknown), Laura Kruper	23
20	Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma 2006 ·Cancer ·Laura Kruper, Francis R. Spitz, Brian J. Czerniecki, Douglas L. Fraker, Anne Blackwood‐Chirchir, Michael E. Ming, David E. Elder, Rosalie Elenitsas, DuPont Guerry, Phyllis A. Gimotty	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact